Krolewiecki A., Enbiale W., Gandasegui J., van Lieshout L., Kepha S., Messa Junior A., Bengtson M., Gelaye W., Escola V., Martinez-Valladares M., Cambra-Pellejà M., Algorta J., Martí-Soler H., Fleitas P., Ballester M.R., Doyle S.R., Williams N.A., Legarda A., Mandomando I., Mwandawiro C., Muñoz J.. An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol. Gates Open Research. 2022; 6DOI:10.12688/gatesopenres.13615.1. PMID:. IF:(Q/D).

De la Serna, E, Puig, O, Mezquida, G, Moreno-Izco, L, Merchan-Naranjo, J, Amoretti, S, Ruiz, P, Gonzalez-Pinto, A, Molina-Garcia, M, Corripio, I, Vieta, E, Baeza, I, Berge, D, Penades, R, Sanchez-Torres, A, Cuesta, MJ, Bernardo, M, Castro-Fornieles, J. Relationship between cognition and age at onset of first-episode psychosis: comparative study between adolescents, young adults, and adults. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2023; 32(4)DOI:10.1007/s00787-021-01901-8. PMID:34714406. IF:6.000(Q1/1D).

Corripio, I, Roldan, A, McKenna, P, Sarro, S, Alonso-Solis, A, Salgado, L, Alvarez, E, Molet, J, Pomarol-Clotet, E, Portella, M. Target selection for deep brain stimulation in treatment resistant schizophrenia. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2022; 112DOI:10.1016/j.pnpbp.2021.110436. PMID:34517055. IF:5.600(Q1/2D).

Dominguez-Clave, E, Soler, J, Elices, M, Franquesa, A, Alvarez, E, Pascual, JC. Ayahuasca may help to improve self-compassion and self-criticism capacities. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 2022; 37(1)DOI:10.1002/hup.2807. PMID:34411343. IF:1.700(Q3/8D).